Clicky

Stagezero Life Sciences Ltd.(SZLS)

Description: StageZero Life Sciences Inc., formerly GeneNews Ltd, is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. The Company is also focused on testing Aristotle application on other disease conditions including neurology, gastroenterology, cardiology, and autoimmune disorders.


Keywords: Medicine Biotechnology Cancer Clinical Medicine Life Sciences Disease Science Disorders Cell Biology Biomarkers Colorectal Cancer Diagnostic Tests Cardiology Platform Technology Neurology Cancer Screening Autoimmune Disorders Cancer Prevention

Home Page: www.stagezerolifesciences.com

SZLS Technical Analysis

70 East Beaver Creek Road
Richmond Hill, ON L4B 3B2
Canada
Phone: 905 209 2030


Officers

Name Title
Mr. James R. Howard-Tripp Exec. Chairman & CEO
Prof. Choong-Chin Liew Co-Founder
Mr. Warren Whitehead C.M.A., CPA Chief Accountant
Mr. David Suria Sr. Scientist

Exchange: TO

Country: CA

Currency: Canadian Dollar (C$)

Forward PE: 3.367
Trailing PE: 0
Price-to-Book MRQ: 3.6184
Price-to-Sales TTM: 1.5381
IPO Date:
Fiscal Year End: December
Full Time Employees: 80
Back to stocks